Reply to Letter to Editor by Fingrut, et al
Blood Adv
.
2024 Oct 25:bloodadvances.2024014712.
doi: 10.1182/bloodadvances.2024014712.
Online ahead of print.
Authors
Nosha Farhadfar
1
,
Stephanie J Lee
2
Affiliations
1
Sarah Cannon Transplant & Cellular Therapy Program at Methodist Hospital, San Antonio, Texas, United States.
2
Fred Hutchinson Cancer Center, Seattle, Washington, United States.
PMID:
39454203
DOI:
10.1182/bloodadvances.2024014712
No abstract available